HomeCRNX • NASDAQ
Follow
Crinetics Pharmaceuticals Inc
Previous close
$44.43
Day range
$44.01 - $47.16
Year range
$15.36 - $47.58
Market cap
3.63B USD
Avg Volume
834.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 185.60M | 31.17% |
Net income | -60.10M | -33.58% |
Net profit margin | — | — |
Earnings per share | -0.90 | -7.14% |
EBITDA | -62.40M | -31.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 558.56M | 67.02% |
Total assets | 635.35M | 80.41% |
Total liabilities | 96.25M | 168.49% |
Total equity | 539.11M | — |
Shares outstanding | 69.60M | — |
Price to book | 5.62 | — |
Return on assets | -24.54% | — |
Return on capital | -26.31% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -60.10M | -33.58% |
Cash from operations | -38.52M | -9.40% |
Cash from investing | -87.31M | -336.91% |
Cash from financing | 37.92M | 32,878.26% |
Net change in cash | -87.90M | -5,091.37% |
Free cash flow | -19.41M | 0.08% |
About
Founded
Nov 18, 2008
Website
Employees
290